Position in KURA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,251,502
+$5,385,225 QoQ
Shares Held
1,663,765
+5.1% QoQ
Ownership
1.87%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#13
of 220 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. KURA ranks #38 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in KURA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,251,502 | 1,663,765 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $12,866,277 | 1,582,568 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,019,580 | 1,830,566 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,657,993 | 865,310 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,098,947 | 1,057,010 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,515,226 | 532,610 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,206,925 | 597,810 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,073,389 | 106,110 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,495,508 | 121,200 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,123,466 | 240,200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,999,078 | 278,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,054,272 | 115,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,990,098 | 188,100 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $203,018 | 16,600 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $1,700,670 | 124,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,657,850 | 145,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,476,672 | 278,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $947,800 | 67,700 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,260,893 | 174,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,300,870 | 302,200 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $848,446 | 85,271 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||